Skip to content
OpenCapital
Get started

NovoCure NVCR Purchases of fixed maturity securities

Purchases of fixed maturity securities at other companies

Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
$58.14M-51.1%
Fulton Financial logo
Fulton FinancialFULT
$200.98M+68.9%
Hyliion logo
HyliionHYLN
$15.17M—
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
$5M0.0%
Hagerty logo
HagertyHGTY
$149.98M+283%
Hilltop Holdings logo
Hilltop HoldingsHTH
$61.38M+49.3%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireHeldToMaturitySecurities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's purchases of fixed maturity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's purchases of fixed maturity securities?
NovoCure (NVCR) reported purchases of fixed maturity securities of $97.1M in Q1 2026.
How has NovoCure's purchases of fixed maturity securities changed year-over-year?
NovoCure's purchases of fixed maturity securities decreased by 16.2% year-over-year, from $115.86M to $97.1M.
What is the long-term trend for NovoCure's purchases of fixed maturity securities?
Over 4 years (2021 to 2025), NovoCure's purchases of fixed maturity securities has grown at a -6.6% compound annual growth rate (CAGR), from $1.08B to $821.08M.
What does purchases of fixed maturity securities mean?
Cash spent purchasing fixed-income securities (bonds, notes, debentures) for the investment portfolio.